Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leucine-rich repeat-containing, G protein-coupled receptors (LGRs) belong to the largest mammalian superfamily of proteins with seven-transmembrane domains. LGRs can be divided into three subgroups based on their unique domain arrangement. Although two subgroups have been found to be receptors for glycoprotein hormones and relaxin-related ligands, respectively, the third LGR subgroup, consisting of
LGR4
-6, are orphan receptors with unknown physiological roles. To elucidate the functions of this subgroup of LGRs,
LGR4
null mice were generated using a secretory trap approach to delete the majority of the
LGR4
gene after the insertion of a
beta-galactosidase
reporter gene immediately after exon 1. Tissues expressing
LGR4
were analyzed based on histochemical staining of the transgene driven by the endogenous
LGR4
promoter.
LGR4
was widely expressed in kidney, adrenal gland, stomach, intestine, heart, bone/cartilage, and other tissues. The expression of
LGR4
in these tissues was further confirmed by immunohistochemical studies in wild-type animals. Analysis of the viability of 250 newborn animals suggested a skewed inheritance pattern, indicating that only 40% of the expected
LGR4
null mice were born. For the
LGR4
null mice viable at birth, most of them died within 2 d. Furthermore, the
LGR4
null mice showed intrauterine growth retardation as reflected by a 14% decrease in body weight at birth, together with 30% and 40% decreases in kidney and liver weights, respectively. The present findings demonstrate the widespread expression of
LGR4
, and an essential role of
LGR4
for embryonic growth, as well as kidney and liver development. The observed pre- and postnatal lethality of
LGR4
null mice illustrates the importance of the
LGR4
signaling system for the survival and growth of animals during the perinatal stage.
...
PMID:Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality. 1519 78
Leucine-rich G-protein-coupled Receptors (LGR) constitute a subfamily of receptors related to glycoprotein hormone receptors. Amongst them,
LGR4
, LGR5 and LGR6 form a cluster for which natural agonists are still unknown. By an extensive gene trapping approach, Leighton et al. (2001) obtained a mouse line in which the
LGR4
gene is disrupted by a trap vector carrying two biological markers, beta-geo (a fusion between bacterial
beta-galactosidase
and neomycin phosphotransferase) and a placental alkaline phosphatase (PLAP). Due to perinatal lethality, characterization of adult mice homozygous for this insertion has been impaired. In the present study we have investigated LacZ and PLAP activity patterns in heterozygous mice as a marker for
LGR4
natural expression at both macroscopic and histological levels. We present a detailed atlas of
LGR4
expression, which displays very wide expression with particularly strong activity in cartilages, kidneys, reproductive tracts and nervous system cells.
...
PMID:Expression pattern of the orphan receptor LGR4/GPR48 gene in the mouse. 1602 69